Literature DB >> 7519799

Diabetogenicity of FK506 versus cyclosporine in liver transplant recipients.

R M Jindal1, I Popescu, M E Schwartz, S Emre, P Boccagni, C M Miller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7519799

Source DB:  PubMed          Journal:  Transplantation        ISSN： 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  5 in total

Review 1.  Medical problems occurring after orthotopic liver transplantation.

Authors:  K L Carson; C M Hunt
Journal:  Dig Dis Sci       Date:  1997-08       Impact factor: 3.199

Review 2.  Post-transplant diabetes mellitus. The role of immunosuppression.

Authors:  R M Jindal; R A Sidner; M L Milgrom
Journal:  Drug Saf       Date:  1997-04       Impact factor: 5.606

Review 3.  Clinical use of tacrolimus (FK-506) in infants and children with renal transplants.

Authors:  D Ellis
Journal:  Pediatr Nephrol       Date:  1995-08       Impact factor: 3.714

Review 4.  The superiority of tacrolimus in renal transplant recipients -- the Pittsburgh experience.

Authors:  R Shapiro; M L Jordan; V P Scantlebury; C Vivas; H A Gritsch; R J Corry; F Egidi; J McCauley; D Ellis; N Gilboa
Journal:  Clin Transpl       Date:  1995

5.  Diabetes as a complication of tacrolimus (FK506) in pediatric renal transplant patients.

Authors:  S Furth; A Neu; P Colombani; L Plotnick; M E Turner; B Fivush
Journal:  Pediatr Nephrol       Date:  1996-02       Impact factor: 3.714
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.